![Edward Dulac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Dulac
Finansdirektör/CFO på
INTELLIA THERAPEUTICS, INC.
Förmögenhet: 2 M $ per 2026-05-31
Profil
Edward J.
Dulac is Chief Financial Officer, Treasurer & Executive VP at Intellia Therapeutics, Inc. since 2024.
Formerly, Mr. Dulac was Chief Financial Officer & Accounting Officer at Fate Therapeutics, Inc. from 2020 to 2024.
Mr. Dulac was Vice President-Business Development & Strategy at Celgene Corp.
from 2017 to 2020.
Mr. Dulac worked as a Research Analyst at Barclays Capital Securities Ltd. from 2009 to 2012 and also held a Research Analyst position at Barclays Capital, Inc. Mr. Dulac was Principal at Pfizer (St. Louis) in 2007, Principal at Brooks Eckerd Pharmacy in 2001, and Principal at CVS, Inc. (Maryland) in 1999.
Mr. Dulac completed undergraduate studies at the University of Pittsburgh in 1998 and earned an MBA from Kelley School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 115 416 ( 0,08 % ) | 2 M $ | 2026-05-31 |
Aktiva positioner av Edward Dulac
| Företag | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Finansdirektör/CFO | 2024-07-22 |
Tidigare kända positioner av Edward Dulac
| Företag | Position | Slut |
|---|---|---|
| FATE THERAPEUTICS, INC. | Finansdirektör/CFO | 2024-06-14 |
| CELGENE | Företagsledare/Principal | 2020-02-01 |
Barclays Capital Securities Ltd.
 Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2011-07-25 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Företagsledare/Principal | 2007-11-30 |
Brooks Eckerd Pharmacy | Företagsledare/Principal | 2001-06-30 |
Edward Dulacs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
84
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Brooks Eckerd Pharmacy | |
CVS, Inc. (Maryland)
 CVS, Inc. (Maryland) Other Consumer ServicesConsumer Services Provides engineering, maintenance, and control programming services for video, audio, and control system | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
